IL-HYATT-HOTELS
14.7.2022 14:02:11 CEST | Business Wire | Press release
To share progress made across World of Care, the company’s Environmental, Social and Governance (ESG) platform, Hyatt Hotels Corporation (NYSE: H) today published its 2021 World of Care Highlights and Diversity, Equity and Inclusion (DE&I) Report to demonstrate how Hyatt is advancing care for the planet, people and responsible business.
“Caring for people so they can be their best has been at the core of Hyatt’s story for 65 years. Through World of Care, we embrace our responsibility and opportunity to work together to shape a more sustainable world and future,” said Margaret Egan, executive vice president and general counsel, Hyatt. “By intently focusing on driving progress against key ESG commitments like our environmental framework and Change Starts Here goals, we are holding ourselves accountable for continued action and progress in order to create the needed changes for our industry, society and planet.”
Hyatt Advances Diverse Workforce Representation
Following last year’s inaugural DE&I report, Hyatt’s 2021 workforce diversity data shows increased levels of representation of people of color across its U.S. workforce, as well as growth across nearly all races and ethnicities among colleagues, managers and leaders. Hyatt’s commitment to share progress annually serves as a critical benchmark to measure the strides made toward a more diverse, equitable and inclusive environment for colleagues.
Hyatt continues to work toward its 2025 DE&I goals around who it employs, supports and works with, outlined as part of its Change Starts Here commitments. With a focus on improving diverse vendor representation across its supply chain, Hyatt welcomed 220 new Black suppliers in 2021, with a continued focus on advancing progress looking ahead. For example, Revival Baltimore, which is part of the JdV by Hyatt brand, worked with Black-owned Black Acres Roastery to supply coffee to all hotel guestrooms and the property’s onsite coffee shop, ‘Dashery, and Hyatt Centric The Pike Long Beach recently welcomed Black-owned brewery Crowns & Hops to its Watercraft Lounge.
“At Hyatt, we believe in the power of belonging – of making people feel at home no matter where they are in the world. We constantly strive to reflect the world we care for with teams that achieve and grow together,” said Malaika Myers, chief human resources officer, Hyatt. “To advance our vision of a world of understanding and care, we must continue to prioritize DE&I across every dimension of our business and take action to make meaningful progress against our goals.”
Hyatt Announces Donation to Launch Human Trafficking Survivor Fund
In an effort to expand the hotel industry’s ongoing work to support human trafficking prevention and survivors, the Hyatt Hotels Foundation has announced a $500,000 donation to launch the “No Room for Trafficking Survivors Fund” in collaboration with the American Hotel & Lodging Association (AHLA). With the donation, and further support from the industry, the Survivors Fund will equip community-based organizations with the resources they need to engage and support survivors – from direct financial support of their short-term, baseline needs to career-related support that can empower and equip them on their path forward.
Hyatt Works to Advance Climate Action
Hyatt further accelerates its efforts to engage in more sustainable business practices as part of its environmental framework – focused on areas of climate change and water conservation, waste and circularity, responsible sourcing and thriving destinations.
In 2021, Hyatt received approval from the Science Based Targets initiative (SBTi) on its 2030 science-based target to reduce greenhouse gas emissions. Hyatt’s targets include reducing absolute scope 1 and 2 emissions, engaging key suppliers to set science-based targets by 2025, and decreasing additional scope 3 emissions.
Hyatt remains diligent in promoting initiatives that support progress toward its science-based target, which focus on energy conservation, efficient technology, building automation systems, advancing sustainable design considerations and more. An important ongoing focus will be on increasing the number of hotels that have on-site solar panels or are using one-hundred percent renewable electricity such as Hyatt Regency Amsterdam and Hyatt Regency Phoenix. Ongoing property efforts are also critical in achieving these targets, such as the ones displayed at Alila Villas Uluwatu through its on-site sustainability lab .
To learn more about Hyatt’s ESG efforts and progress, visit Hyatt.com/WorldofCare or browse the 2021 World of Care Highlights , 2021 DE&I Report and 2021 GRI Index .
The term “Hyatt” is used in this release for convenience to refer to Hyatt Hotels Corporation and/or one or more of its affiliates.
About Hyatt Hotels Corporation
Hyatt Hotels Corporation, headquartered in Chicago, is a leading global hospitality company guided by its purpose – to care for people so they can be their best. As of March 31, 2022, the Company’s portfolio included more than 1,150 hotels and all-inclusive properties in 71 countries across six continents. The Company's offering includes the Park Hyatt®, Miraval®, Grand Hyatt®, Alila®, Andaz®, The Unbound Collection by Hyatt®, Destination by Hyatt™, Hyatt Regency®, Hyatt®, Hyatt Ziva™, Hyatt Zilara™, Thompson Hotels®, Hyatt Centric®, Caption by Hyatt, JdV by Hyatt™, Hyatt House®, Hyatt Place®, UrCove, and Hyatt Residence Club® brands, as well as resort and hotel brands under the AMR™ Collection, including Secrets® Resorts & Spas, Dreams® Resorts & Spas, Breathless Resorts & Spas®, Zoëtry® Wellness & Spa Resorts, Vivid Hotels & Resorts®, Alua Hotels & Resorts®, and Sunscape® Resorts & Spas. Subsidiaries of the Company operate the World of Hyatt® loyalty program, ALG Vacations®, Unlimited Vacation Club®, Amstar DMC destination management services, and Trisept Solutions® technology services. For more information, please visit www.hyatt.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005967/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
